PDPK1 and renal cell carcinoma: Our study confirms that targeting PDPK1 inhibits the phosphorylation of Akt1 and, through a cascade of downstream effects, suppresses mTORC1 activity, which is related to protein synthesis, cell growth, apoptosis, and autophagy in RCC.